MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from sale of
common shares
$29,143K
Net provided by
financing activities
$28,072K
Canceled cashflow
$1,071K
Net change in cash,
cash equivalents and...
$2,583K
Canceled cashflow
$25,489K
Repayment of financing
lease obligations
$510K
Financing costs to issue
common shares
$487K
Taxes paid related to
net share...
$72K
Contingent consideration
liability payments
$2K
Impairment losses
$14,600K
Change in fair value of
contingent consideration
$5,946K
Accounts payable and
accrued liabilities
$2,646K
Stock-based compensation
$2,219K
Depreciation and
amortization expense
$2,190K
Accounts receivable
-$485K
Unrealized foreign
currency losses (gains)
-$185K
Equity compensation
for bonus awards and...
$164K
Amortization of intangible
assets
$7K
Net cash used in
operating activities
-$22,184K
Net cash used in
investing activities
-$3,185K
Effect of exchange rate
changes on cash and cash...
-$120K
Canceled cashflow
$28,442K
Other income, net
$1,011K
Net loss
-$50,222K
Machinery and equipment
purchases, and...
$3,185K
Canceled cashflow
$1,011K
Prepaid expenses and
other assets
$226K
Operating lease assets and
liabilities
-$142K
Inventories
$36K
Segment loss from
operations
-$26,162K
Impairment losses
$14,600K
Change in fair value of
contingent consideration
$5,946K
Stock-based compensation
$2,219K
Depreciation and
amortization expenses
$2,197K
Interest expense
-$109K
Back
Back
Cash Flow
source: myfinsight.com
Insight Molecular Diagnostics Inc. (IMDX)
Insight Molecular Diagnostics Inc. (IMDX)